Prague Med. Rep. 2015, 116, 181-192

https://doi.org/10.14712/23362936.2015.57

Ormond’s Disease – IgG4-related Disease

Miroslav Průcha1, Ivan Kolombo2, Petr Štádler3

1Department of Clinical Biochemistry, Haematology and Immunology, Na Homolce Hospital, Prague, Czech Republic
2Department of Urology, Third Faculty of Medicine, Charles University in Prague and University Hospital Královské Vinohrady, Prague, Czech Republic
3Department of Vascular Surgery, Na Homolce Hospital, Prague, Czech Republic

Received March 9, 2015
Accepted September 15, 2015

References

1. Adler, S., Lodermeyer, S., Gaa, J., Heemann, U. (2008) Successful mycophenolate mofetil therapy in nine patients with idiopathic retroperitoneal fibrosis. Rheumatology 47, 1535–1538. <https://doi.org/10.1093/rheumatology/ken291>
2. Albarran, J. (1905) Rétention rénale par péri-urétérite. Libération externe de l’uretere. Assoc. Fr. Urol. 9, 511–517.
3. Binder, M., Uhl, M., Wiech, T., Kollert, F., Thiel, J., Sass, J. O., Walker, U. A., Peter, H. H., Warnatz, K. (2012) Cyclophosphamide is a highly effective and safe induction therapy in chronic periaortitis: a long-term follow-up of 35 patients with chronic periaortitis. Ann. Rheum. Dis. 71, 311–312. <https://doi.org/10.1136/annrheumdis-2011-200148>
4. Brandt, A. S., Kamper, L., Kukuk, S., Haage, P., Roth, S. (2014) Tamoxifen monotherapy in the treatment of retroperitoneal fibrosis. Urol. Int. 93, 320–325. <https://doi.org/10.1159/000357814>
5. Brito-Zerón, P., Ramos-Casals, M., Bosch, X., Stone, J. H. (2014) The clinical spectrum of IgG4-related disease. Autoimmun. Rev. 13, 1203–1210. <https://doi.org/10.1016/j.autrev.2014.08.013>
6. Cartery, C., Astudillo, L., Deelchand, A., Moskovitch, G., Sailler, L., Bossavy, J. P., Arlet, P. (2011) Abdominal infectious aortitis caused by Streptococcus pneumoniae: a case report and literature review. Ann. Vasc. Surg. 25, 266.e9–266.e16. <https://doi.org/10.1016/j.avsg.2010.07.014>
7. Catanoso, M. G., Spaggiari, L., Magnani, L., Pipitone, N., Versari, A., Boiardi, L., Pazzola, G., Pattacini, P., Salvarani, C. (2012) Efficacy of infliximab in a patient with refractory idiopathic retroperitoneal fibrosis. Clin. Exp. Rheumatol. 30, 776–777.
8. Corradi, D., Maestri, R., Palmisano, A., Bosio, S., Greco, P., Manenti, L., Ferretti, S., Cobelli, R., Moroni, G., Dei Tos, A. P., Buzio, C., Vaglio, A. (2007) Idiopathic retroperitoneal fibrosis: Clinicopathologic features and differential diagnostic. Kidney Int. 72, 742–753. <https://doi.org/10.1038/sj.ki.5002427>
9. Couderc, M., Mathieu, S., Dubost, J. J., Soubrier, M. (2012) Retroperitoneal fibrosis during etanercept therapy for rheumatoid arthritis. J. Rheumatol. 40, 1931–1933. <https://doi.org/10.3899/jrheum.130324>
10. Cutolo, M., Sulli, A., Capellino, S., Villaggio, B., Montagna, P., Seriolo, B., Straub, R. H. (2004) Sex hormones influence on the immune system: basic and clinical aspects in autoimmunity. Lupus 13, 635–638. <https://doi.org/10.1191/0961203304lu1094oa>
11. Dahlgren, M., Khosroshahi, A., Nielsen, G. P., Desphande, V., Stone, J. H. (2010) Riedels thyroiditis and multifocal fibrosclerosis are part of the IgG4-related systemic disease spectrum. Arthritis Care Res. (Hoboken) 62, 1312–1318. <https://doi.org/10.1002/acr.20215>
12. Fry, A. C., Singh, S., Gunda, S. S., Boustead, G. B., Hanbury, D. C., McNicholas, T. A., Farrington, K. (2008) Successful use of steroids and ureteric stents in 24 patients with idiopathic retroperitoneal fibrosis: a retrospective study. Nephron Clin. Pract. 108(3), c213–c220. <https://doi.org/10.1159/000119715>
13. Garvin, S., Dabrosin, C. (2003) Tamoxifen inhibits secretion of vascular endothelial growth factor in breast cancer in vivo. Cancer Res. 63, 8742–8748.
14. Gilkeson, G. S., Allen, N. B. (1996) Retroperitoneal fibrosis. A true connective tissue disease. Rheum. Dis. Clin. North Am. 22, 23–38. <https://doi.org/10.1016/S0889-857X(05)70260-X>
15. Kava, B. R., Russo, P., Conlon, K. C. (1996) Laparoscopic diagnosis of malignant retroperitoneal fibrosis. J. Endourol. 10, 535–538. <https://doi.org/10.1089/end.1996.10.535>
16. Khosroshahi, A., Carruthers, M. N., Stone, J. H., Shinagare, S., Sainani, N., Hasserjian, R. P., Deshpande, V. (2013) Rethinking Ormond’s disease: “idiopathic” retroperitoneal fibrosis in the era of IgG4-related disease. Medicine (Baltimore) 92, 82–91. <https://doi.org/10.1097/MD.0b013e318289610f> <PubMed>
17. Kolombo, I., Toběrný, M., Černohorský, S. (2008) Robotic surgery in urology. New EU Magazine of Medicine 2, 84–93.
18. Koo, B. S., Koh, Y. W., Hong, S., Kim, Y. J., Kim, Y. G., Lee, C. K., Yoo, B. (2014) Clinicopathologic characteristics of IgG4-related retroperitoneal fibrosis among patients initially diagnosed as having idiopathic retroperitoneal fibrosis. Mod. Rheumatol. 1, 1–5.
19. Kuhn, M. A., Wang, X., Payne, W. G., Ko, F., Robson, M. C. (2002) Tamoxifen decreases fibroblast function and downregulates TGF(beta2) in Dupuytren’s affected palmar fascia. J. Surg. Res. 103, 146–152. <https://doi.org/10.1006/jsre.2001.6350>
20. Laco, J., Podhola, M., Kamaradova, K., Novak, I., Dobes, D., Brodak, M., Hacova, M., Ryska, A. (2013) Idiopathic vs. secondary retroperitoneal fibrosis: A clinicopathological study of 12 cases with emphasis to possible relationship to IgG4-related disease. Virchovs Arch. 463, 721–730. <https://doi.org/10.1007/s00428-013-1480-7>
21. Maritati, F., Corradi, D., Versari, A., Casali, M., Urban, M. L., Buzio, C., Vaglio, A. (2012) Rituximab therapy for chronic periaortitis. Ann. Rheum. Dis. 71, 1262–1264. <https://doi.org/10.1136/annrheumdis-2011-201166>
22. Marzano, A., Trapani, A., Leone, N., Actis, G. C., Rizzetto, M. (2001) Treatment of idiopathic retroperitoneal fibrosis using cyclosporin. Ann. Rheum. Dis. 60, 427–428. <https://doi.org/10.1136/ard.60.4.427> <PubMed>
23. McMurray, R. W. (2001) Estrogen, prolactin, and autoimmunity: actions and interactions. Int. Immunopharmacol. 1(6), 995–1008. <https://doi.org/10.1016/S1567-5769(01)00045-5>
24. Moroni, G., Gallelli, B., Banfi, G., Sandri, S., Messa, P., Ponticelli, C. (2006) Long-term outcome of idiopathic retroperitoneal fibrosis treated with surgical and/or medical approaches. Nephrol. Dial. Transplant. 21, 2485–2490. <https://doi.org/10.1093/ndt/gfl228>
25. Ormond, J. K. (1948) Bilateral ureteral obstruction due to envelopment and compression by an inflammatory retroperitoneal process. J. Urol. 59, 1072–1079. <https://doi.org/10.1016/S0022-5347(17)69482-5>
26. Parums, D. V. (1990) The spectrum of chronic periaortitis. Histopathology 16, 423–431. <https://doi.org/10.1111/j.1365-2559.1990.tb01541.x>
27. Pelkmans, L. G., Aarnoudse, A. J., Hendriksz, T. R., van Bommel, E. F. (2012) Value of acute-phase reactants in monitoring disease activity and treatment response in idiopathic retroperitoneal fibrosis. Nephrol. Dial. Transplant. 27, 2819–2825. <https://doi.org/10.1093/ndt/gfr779>
28. Restrepo, C. S., Ocazionez, D., Suri, R., Vargas, D. (2011) Aortitis: Imaging spectrum of the infectious and inflammatory conditions of the aorta. Radiographics 31, 435–431. <https://doi.org/10.1148/rg.312105069>
29. Scheel, P. J. Jr., Feeley, N., Sozio, S. M. (2011) Combined prednisone and mycophenolate mofetil treatment for retroperitoneal fibrosis: a case series. Ann. Intern. Med. 154, 31–36. <https://doi.org/10.7326/0003-4819-154-1-201101040-00005>
30. Schmidt, W. A. (2013) Imaging vasculitis. Best Pract. Res. Clin. Rheumatol. 27, 107–118. <https://doi.org/10.1016/j.berh.2013.01.001>
31. Sedivy, P., Spacek, M., El Samman, K., Belohlavek, O., Mach, T., Jindrak, V., Rohn, V., Stadler, P. (2012) Endovascular treatment of infected aortic aneurysms. Eur. J. Vasc. Endovasc. Surg. 44, 385–394. <https://doi.org/10.1016/j.ejvs.2012.07.011>
32. Seth, A., Ansari, M. S., Trikha, V., Mittal, R. (2001) Retroperitoneal fibrosis: a rare complication of Pott’s disease. J. Urol. 166, 622–623. <https://doi.org/10.1016/S0022-5347(05)66007-7>
33. Swartz, R. D., Lake, A. M., Roberts, W. W., Faerber, G. J., Wolf, J. S. Jr. (2008) Idiopathic retroperitoneal fibrosis: a role for mycophenolate mofetil. Clin. Nephrol. 69, 260–268. <https://doi.org/10.5414/CNP69260>
34. Takahashi, H., Yamamoto, M., Suzuki, C., Naishiro, Y., Shinomura, Y., Imai, K. (2010) The birthday of a new syndrome: IgG4 related diseases constitute a clinical entity. Autoimmun. Rev. 9, 591–594. <https://doi.org/10.1016/j.autrev.2010.05.003>
35. Vaglio, A., Buzio, C. (2005) Chronic periaortitis: a spectrum of diseases. Curr. Opin. Rheumatol. 17, 34–40. <https://doi.org/10.1097/01.bor.0000145517.83972.40>
36. Vaglio, A., Corradi, D., Manenti, L., Ferretti, S., Garini, G., Buzio, C. (2003) Evidence of autoimunity in chronic periaortitis: a prospective study. Am. J. Med. 114, 454–462. <https://doi.org/10.1016/S0002-9343(03)00056-1>
37. Vaglio, A., Salvarani, C., Buzio, C. (2006) Retroperitoneal fibrosis. Lancet 367, 241–251. <https://doi.org/10.1016/S0140-6736(06)68035-5>
38. Vaglio, A., Catanoso, M. G., Spaggiari, L., Magnani, L., Pipitone, N., Macchioni, P., Pulsatelli, L., Nicastro, M., Becchi, G., Corradi, D., Versari, A., Boiardi, L., Salvarani, C. (2013) Interleukin-6 as an inflammatory mediator and target of therapy in chronic periaortitis. Arthritis Rheum. 65, 2469–2475. <https://doi.org/10.1002/art.38032>
39. van Bommel, E. F., Siemes, C., Hak, L. E., van der Veer, S. J., Hendriksz, T. R. (2007) Long-term renal and patient outcome in idiopathic retroperitoneal fibrosis treated with prednisone. Am. J. Kidney Dis. 49, 615–625. <https://doi.org/10.1053/j.ajkd.2007.02.268>
40. van Bommel, E. F., Jansen, I., Hendriksz, T. R., Aarnoudse, A. L. (2009) Idiopathic retroperitoneal fibrosis: Prospective evaluation of incidence and clinicoradiologic presentation. Medicine (Baltimore) 88, 193–201. <https://doi.org/10.1097/MD.0b013e3181afc420>
41. van Bommel, E. F., Pelkmans, L. G., van Damme, H., Hendriksz, T. R. (2013) Long-term safety and efficacy of a tamoxifen – Based treatment strategy for idiopathic retroperitoneal fibrosis. Eur. J. Intern. Med. 24, 444–450. <https://doi.org/10.1016/j.ejim.2012.11.010>
42. Warnatz, K., Keskin, A. G., Uhl, M., Scholz, C., Katzenwadel, A., Vaith, P., Peter, H. H., Walker, U. A. (2005) Immunosuppressive treatment of chronic periaortitis: a retrospective study of 20 patients with chronic periaortitis and a review of the literature. Ann. Rheum. Dis. 64, 828–833. <https://doi.org/10.1136/ard.2004.029793> <PubMed>
43. Zen, Y., Onodera, M., Inoue, D., Kitao, A., Matsui, O., Nohara, T., Namikim, M., Kasashima, S., Kawashima, A., Matsumoto, Y., Katayanagi, K., Murata, T., Ishizawa, S., Hosaka, N., Kuriki, K., Nakanuma, Y. (2009) Retroperitoneal fibrosis: A clinicopathologic study with respect to immunoglobulin G4. Am. J. Surg. Pathol. 33, 1833–1839. <https://doi.org/10.1097/PAS.0b013e3181b72882>
44. Zen, Y., Kasashima, S., Inoue, D. (2012) Retroperitoneal and aortic manifestations of immunoglobulin G4-related disease. Semin. Diagn. Pathol. 29, 212–218. <https://doi.org/10.1053/j.semdp.2012.07.003>
front cover

ISSN 1214-6994 (Print) ISSN 2336-2936 (Online)

Archive